American Portfolios Advisors’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$329K Sell
1,508
-70
-4% -$15.9K 0.01% 813
2022
Q2
$331K Sell
1,578
-8
-0.5% -$1.7K 0.01% 838
2022
Q1
$385K Sell
1,586
-89
-5% -$21.5K 0.01% 859
2021
Q4
$436K Buy
1,675
+150
+10% +$38.9K 0.01% 801
2021
Q3
$402K Sell
1,525
-38
-2% -$10.4K 0.02% 807
2021
Q2
$385K Buy
1,563
+11
+0.7% +$2.31K 0.01% 836
2021
Q1
$301K Buy
1,552
+61
+4% +$12.2K 0.01% 866
2020
Q4
$317K Sell
1,491
-49
-3% -$9.77K 0.02% 714
2020
Q3
$264K Sell
1,540
-1,626
-51% -$300K 0.02% 698
2020
Q2
$608K Buy
3,166
+66
+2% +$10.8K 0.04% 383
2020
Q1
$457K Buy
3,100
+1,299
+72% +$207K 0.04% 391
2019
Q4
$279K Buy
1,801
+65
+4% +$9.37K 0.02% 624
2019
Q3
$235K Sell
1,736
-373
-18% -$48.9K 0.02% 655
2019
Q2
$257K Buy
2,109
+17
+0.8% +$1.88K 0.02% 608
2019
Q1
$218K Buy
2,092
+416
+25% +$42.9K 0.02% 610
2018
Q4
$191K Buy
1,676
+37
+2% +$3.96K 0.02% 526
2018
Q3
$189K Sell
1,639
-50
-3% -$5.48K 0.02% 606
2018
Q2
$175K Sell
1,689
-17
-1% -$1.72K 0.02% 602
2018
Q1
$168K Sell
1,706
-335
-16% -$31.7K 0.03% 579
2017
Q4
$173K Buy
+2,041
New +$169K 0.03% 552

Other funds holding RMD

American Portfolios Advisors's RMD Position: Q3 2022 in Review

American Portfolios Advisors reduced its ResMed (RMD) stake by 4.4% in Q3 2022, selling an estimated $15.9K and leaving 1,508 shares worth $329K. The position accounts for 0.01% of the portfolio, ranked #813.

American Portfolios Advisors first reported a position in RMD in Q4 2017 and has held it in 20 quarters since. The position peaked at $608K in Q2 2020. 668 funds tracked by Wall St. Rank hold RMD as of Q3 2022.

  • American Portfolios Advisors held 1,508 shares of ResMed worth $329K as of Q3 2022.
  • American Portfolios Advisors sold 70 ResMed shares in Q3 2022, an estimated $15.9K.
  • ResMed made up 0.01% of American Portfolios Advisors's portfolio in Q3 2022, its #813 holding.
  • American Portfolios Advisors first reported a position in ResMed in Q4 2017 and has held it in 20 quarters since.
  • American Portfolios Advisors's ResMed position peaked at $608K in Q2 2020.
  • 668 funds tracked by Wall St. Rank held ResMed as of Q3 2022.

Based on American Portfolios Advisors's 13F filing for Q3 2022, filed 17 Mar 2023.